Company Filing History:
Years Active: 2021
Title: Rachel Weissman-Tsukamoto: Innovator in Therapeutic and Diagnostic Methods
Introduction
Rachel Weissman-Tsukamoto is a prominent inventor based in Stanford, California. She has made significant contributions to the field of therapeutic and diagnostic methods, particularly in relation to cancer treatment. Her innovative work focuses on manipulating phagocytosis through calreticulin and low-density lipoprotein-related receptors.
Latest Patents
Rachel holds a patent for "Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low-density lipoprotein-related receptor." This patent outlines methods that relate to the expression of calreticulin on cancer cells and hematopoietic cells. Her groundbreaking research aims to enhance the understanding and treatment of cancer.
Career Highlights
Rachel is affiliated with Leland Stanford Junior University, where she continues her research and development in the field of cancer therapeutics. Her work has garnered attention for its potential impact on cancer treatment methodologies.
Collaborations
Rachel has collaborated with notable colleagues, including Mark P Chao and Siddhartha Jaiswal. These partnerships have further enriched her research and contributed to advancements in therapeutic techniques.
Conclusion
Rachel Weissman-Tsukamoto is a trailblazer in the field of therapeutic and diagnostic methods, with a focus on cancer treatment. Her innovative patent and collaborations highlight her commitment to advancing medical science.